Mainolfi Nello

Chief Executive Officer

Mainolfi Nello has filed 11 SEC Form 4 filings (38 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Oct 1, 2026.

On the most recent filing, Mainolfi Nello is listed as Chief Executive Officer at Kymera Therapeutics, Inc. Inside the rolling window, Mainolfi Nello reported no open-market purchases and 8 open-market sales totaling $36.8M in KYMR. The largest disclosed transaction in the window is a sale of 80,000 KYMR shares on Jul 1, 2026, worth $9.2M.

Companies traded

Other insiders at KYMR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$36.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KYMRSale$3.4MOct 1SEC ↗
KYMRSale$6.0MJul 8SEC ↗
KYMRSale$9.2MJul 2SEC ↗
KYMRSale$2.4MApr 29SEC ↗
KYMRSale$2.7MFeb 25SEC ↗
KYMRSale$2.3MDec 31SEC ↗
KYMRSale$8.9MDec 8SEC ↗
KYMRSale$1.8MOct 29SEC ↗
Showing 1–8 of 8
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 16, 2025KYMRSale$1.5M
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mainolfi Nello made?

Mainolfi Nello has filed 11 SEC Form 4 filings (38 transaction rows) across 1 company since 2025.

Which companies does Mainolfi Nello trade?

Mainolfi Nello has filed SEC Form 4 disclosures for 1 company, including KYMR.

When was Mainolfi Nello's most recent SEC Form 4 filing?

Mainolfi Nello's most recent SEC Form 4 filing on Tracefour is dated Oct 1, 2026.

What is Mainolfi Nello's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Mainolfi Nello is listed as Chief Executive Officer.

What is Mainolfi Nello's total buy and sell value in the current window?

Inside the rolling retention window, Mainolfi Nello bought $0 and sold $36.8M based on SEC Form 4 filings.

What was Mainolfi Nello's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 80,000 KYMR shares on 2026-07-01, worth $9.2M, per SEC Form 4 filings.